文献速递胸部肿瘤放疗放疗物理与技术

肺癌放疗计划中MRI、CT与PET-CT靶区及淋巴结勾画变异性比较

Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-05-06

研究比较7名医师在CT、PET-CT融合及MRI(T1加权联合弥散加权)上勾画10例肺癌原发灶及转移淋巴结的观察者间变异性。结果显示各模态间体积差异不显著,但观察者间归一化体积变异达1.6-2.0倍;肿瘤-肺不张界面变异性最高。

要点

  • MRI与CT勾画体积相对PET-CT的比值分别为1.38和1.62,但差异无统计学意义。
  • 观察者间归一化体积变异因子MRI为1.6,CT和PET-CT均为2.0。

核心结论

  • 尽管MRI勾画的总体变异性大于PET-CT,但勾画变异性取决于界面类型,各模态间差异不显著。
  • 多模态成像及结合不同成像特征可能是最准确确定肿瘤体积的方法。

研究设计与样本

  • 7名医师对10例肺癌患者的原发灶及病理淋巴结进行勾画,比较CT、PET-CT融合及MRI三种场景。
  • 以所有观察者轮廓的中位表面作为参考,分析体积及双向局部距离,医师标注界面类型。

主要发现

  • CT和MRI相对PET-CT的归一化肿瘤体积分别为1.62±0.76和1.38±0.44,模态间体积差异不显著。
  • 观察者间每例平均归一化体积变异因子MRI为1.6、CT和PET-CT为2.0(P=4.10×10^-5至3.82×10^-9)。
  • 不确定性最小的界面为肿瘤-肺(CT)和肿瘤-纵隔(PET-CT和MRI)。

关键数值与推荐

  • CT和MRI相对PET-CT的归一化肿瘤体积分别为1.62±0.76和1.38±0.44。
  • 观察者间归一化体积变异因子MRI为1.6,CT和PET-CT为2.0(P=4.10×10^-5至3.82×10^-9)。

临床怎么用

  • 勾画肺癌靶区时应关注肿瘤-肺不张界面的高变异性,可能需要多模态成像辅助。
  • 结合MRI、CT和PET-CT的不同成像特征可能有助于更准确地确定肿瘤体积。

局限性

  • 观察者对MRI的经验有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate interobserver delineation variability for gross tumor volumes of primary lung tumors and associated pathologic lymph nodes using magnetic resonance imaging (MRI), and to compare the results with computed tomography (CT) alone- and positron emission tomography (PET)-CT-based delineations. METHODS AND MATERIALS: Seven physicians delineated the tumor volumes of 10 patients for the following scenarios: (1) CT only, (2) PET-CT fusion images registered to CT ("clinical standard"), and (3) postcontrast T1-weighted MRI registered with diffusion-weighted MRI. To compute interobserver variability, the median surface was generated from all observers' contours and used as the reference surface. A physician labeled the interface types (tumor to lung, atelectasis (collapsed lung), hilum, mediastinum, or chest wall) on the median surface. Contoured volumes and bidirectional local distances between individual observers' contours and the reference contour were analyzed. RESULTS: Computed tomography- and MRI-based tumor volumes normalized relative to PET-CT-based volumes were 1.62 ± 0.76 (mean ± standard deviation) and 1.38 ± 0.44, respectively. Volume differences between the imaging modalities were not significant. Between observers, the mean normalized volumes per patient averaged over all patients varied significantly by a factor of 1.6 (MRI) and 2.0 (CT and PET-CT) (P=4.10 × 10-5 to 3.82 × 10-9). The tumor-atelectasis interface had a significantly higher variability than other interfaces for all modalities combined (P=.0006). The interfaces with the smallest uncertainties were tumor-lung (on CT) and tumor-mediastinum (on PET-CT and MRI). CONCLUSIONS: Although MRI-based contouring showed overall larger variability than PET-CT, contouring variability depended on the interface type and was not significantly different between modalities, despite the limited observer experience with MRI. Multimodality imaging and combining different imaging characteristics might be the best approach to define the tumor volume most accurately.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Karki K, Saraiya S, Hugo GD, et al. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816167. doi:10.1016/j.ijrobp.2017.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。